title: In this issue: Antibodies in pathogenesis and management of diseases.
authors.affiliation: a Associate Editor in Chief, International Reviews of Immunology and Associate Professor , Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER) , Bhopal , India.
authors.forename: Himanshu
authors.initials: H
authors.lastname: Kumar
authors.affiliation: b Editor in Chief, International Reviews of Immunology and Vice President, Translational Sciences , Kite Pharma Inc. , Santa Monica , California , USA.
authors.forename: Adrian
authors.initials: A
authors.lastname: Bot
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology* / Q000628:therapy; D053264:B-Cell Activating Factor / Q000276:immunology; D003165:Complement System Proteins / Q000378:metabolism; D006801:Humans; D056724:Immunity, Humoral; D007167:Immunotherapy / Q000379:methods*; D007239:Infections / Q000276:immunology* / Q000628:therapy; D010587:Phagocytosis; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology* / Q000628:therapy; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000276:immunology
chemical_list: D000906:Antibodies; D053264:B-Cell Activating Factor; C505719:TNFSF13B protein, human; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13; D003165:Complement System Proteins